Recent studies demonstrated that reduction of α-secretase activity can cause AD.31 Moreover, a modest elevation of ADAM10 activity may be beneficial for AD and is well tolerated in adult brain, supporting the hypothesis that therapeutic strategies for increasing α-secretase activity via ADAM10 upregulation are predicted to be efficacious for AD.31, 32, 33. The gene discussed is ADAM10; the disease is Alzheimer disease.